Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)

Norbert Gleicher, Andrea Weghofer, David H Barad, Norbert Gleicher, Andrea Weghofer, David H Barad

Abstract

Background: Dehydroepiandrosterone (DHEA) has been reported to improve pregnancy chances in women with diminished ovarian reserve (DOR), and to reduce miscarriage rates by 50-80%. Such an effect is mathematically inconceivable without beneficial effects on embryo ploidy. This study, therefore, assesses effects of DHEA on embryo aneuploidy.

Methods: In a 1:2, matched case control study 22 consecutive women with DOR, supplemented with DHEA, underwent preimplantation genetic screening (PGS) of embryos during in vitro fertilization (IVF) cycles. Each was matched by patient age and time period of IVF with two control IVF cycles without DHEA supplementation (n = 44). PGS was performed for chromosomes X, Y, 13, 16, 18, 21 and 22, and involved determination of numbers and percentages of aneuploid embryos.

Results: DHEA supplementation to a significant degree reduced number (P = 0.029) and percentages (P < 0.001) of aneuploid embryos, adjusted for relevant covariates. Short term supplementation (4-12 weeks) resulted in greatest reduction in aneuploidy (21.6%, 95% CI -2.871-46.031).

Discussion: Beneficial DHEA effects on DOR patients, at least partially, are the likely consequence of lower embryo aneuploidy. DHEA supplementation also deserves investigation in older fertile women, attempting to conceive, where a similar effect, potentially, could positively affect public health.

Figures

Figure 1
Figure 1
Comparison of absolute and percentages of aneuploidy in DHEA and control patients.

References

    1. Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocytes and embryo yields, embryo grade and cell number in IVF. Hum Reprod. 2006;21:2845–2849. doi: 10.1093/humrep/del254.
    1. Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet. 2007;24:629–634. doi: 10.1007/s10815-007-9178-x.
    1. Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A, Shulman A. Addition of dehydroepiandrosterone (DHEA for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod. 2010;25:2496–2500. doi: 10.1093/humrep/deq220.
    1. Gleicher N, Weghofer A, Barad D. Increased euploid embryos after supplementation with dehydroepiandrosterone (DHEA) in women with premature ovarian aging. Fertil Steril. 2007;88(Suppl 1):S232. doi: 10.1016/j.fertnstert.2007.07.792.
    1. Eichenlaub-Ritter U. Parentral age-related aneuploidy in human germ cells and offspring: a story of past and present. Environ Mol Mutagen. 1996;28:211–236. doi: 10.1002/(SICI)1098-2280(1996)28:3<211::AID-EM6>;2-G.
    1. Wyrobek AJ, Aardema M, Eichenlaub-Ritter U, Ferguson L, Marchetti F. Mechanisms and targets involved in maternal and paternal age effects on numerical aneuploidy. Environ Mol Mutagen. 1996;28:254–264. doi: 10.1002/(SICI)1098-2280(1996)28:3<254::AID-EM9>;2-D.
    1. Twisk M, Mastenbroek S, van Wely M, Heineman MJ, Van der Veen F, Repping S. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilization or intracytoplasmic sperm injection. Cochrane Database Syst Rev. 2006;25(1):CD005291.
    1. Gleicher N, Weghofer A, Barad D. Preimplantation genetic screening: "established" and ready for prime time? Fertil Steril. 2008;89:780–788. doi: 10.1016/j.fertnstert.2008.01.072.
    1. Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeven HR, Vogel NE, Arts EG, de Vries JW, Bossuyt PM, Buys CH, Heineman MJ, Repping S, van der Veen F. In vitro fertilization with preimplantation genetic screening. N Engl J Med. 2007;357:9–17. doi: 10.1056/NEJMoa067744.
    1. Gleicher N, Ryan E, Weghofer A, Blanco-Mejia S, Barad DH. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod Biol Endocrinol. 2009;7:108. doi: 10.1186/1477-7827-7-108.
    1. Bettio D, Venci A, Levi Setti PE. Chromosomal abnormalities in miscarriages after different assisted reproduction procedures. Placenta. 2008;29(Suppl B):126–8. doi: 10.1016/j.placenta.2008.08.015.
    1. Barad DH, Weghofer A, Gleicher N. Age-specific levels for basal follicle-stimulatng hormone assessment of ovarian function. Obstet Gynecol. 2007;109:14014–1410.
    1. Barad DH, Weghofer A, Goyal A, Gleicher N. Age-specific anti-Müllerian hormone (AMH): Utility of AMH at various ages. Reprod Biomed Online. in press .
    1. Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet. 2007;24:629–634. doi: 10.1007/s10815-007-9178-x.
    1. Weghofer A, Munné S, Brannath W, Chen S, Tomkin G, Cekleniak N, Garrisi M, Barad D, Cohen J, Gleicher N. The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation. Hum Reprod. 2008;23:499–503. doi: 10.1093/humrep/dem412.
    1. Weghofer A, Munné S, Brannath W, Chen S, Barad D, Cohen J, Gleicher N. The impact of LH-containing gonadotropins stimulation on euploidy rates in preimplantation embryos: antagonist cycles. Fertil Steril. 2009;92:937–942. doi: 10.1016/j.fertnstert.2008.07.1735.
    1. Herbert D, Lucke J, Dobson A. Pregnancy losses in young Australian women: findings from the Australian Longitudinal Study of Women's Health. Womens Health Issues. 2009;19:21–29. doi: 10.1016/j.whi.2008.08.007.
    1. Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT, Scott RT Jr. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril. 2001;76:666–669. doi: 10.1016/S0015-0282(01)02017-9.
    1. Gleicher N, Weghofer A, Barad DH. Improvement in diminished ovarian reserve after dehydroepiandrosterone (DHEA) supplementation. Reprod Biomed Online. 2010;21:360–365. doi: 10.1016/j.rbmo.2010.04.006.
    1. Jacob MH, da R, Janner D, Jahn MP, Kucharski LC, Belló-Klein A, Ribeiro MF. Age-related effects of DHEA on peripheral markers of oxidative stress. Cell Biochem Funct. 2010;28:52–57. doi: 10.1002/cbf.1619.
    1. Hodges CA, Ilagan A, Jenninger D, Keri R, Nilson J, Hunt PA. Experimental evidence that changes in oocyte growth influence meiotic chromosome segregation. Hum Reprod. 2002;17:1171–1180. doi: 10.1093/humrep/17.5.1171.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj